Intermolecular Stock Price, News & Analysis (NASDAQ:IMI)

$1.25 -0.01 (-0.79 %)
(As of 12/12/2017 08:51 AM ET)
Previous Close$1.26
Today's Range$1.21 - $1.31
52-Week Range$0.80 - $1.65
Volume26,800 shs
Average Volume43,913 shs
Market Capitalization$62.44 million
P/E RatioN/A
Dividend YieldN/A
Beta1.13

About Intermolecular (NASDAQ:IMI)

Intermolecular logoIntermolecular, Inc. provides thin film solutions. The Company's high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems. It develops technology and Internet protocol (IP) rights focused on materials, processes, integration and device architectures in collaboration with its customers. Its HPC platform consists of tempus HPC processing, automated characterization and informatics and analysis software. The Company offers a series of wet processing tools and dry processing tools. Its informatics software includes workflow management software, analysis and reporting software, security and collaboration management software, and integration services. It caters to semiconductor device, semiconductor materials and equipment and clean energy market companies.

Receive IMI News and Ratings via Email

Sign-up to receive the latest news and ratings for IMI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Semiconductors
Sub-IndustrySemiconductors
SectorComputer and Technology
SymbolNASDAQ:IMI
CUSIP45882D10
Phone408-582-5700

Debt

Debt-to-Equity RatioN/A
Current Ratio4.40%
Quick Ratio4.40%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$47.30 million
Price / Sales1.31
Cash FlowN/A
Price / CashN/A
Book Value$0.91 per share
Price / Book1.37

Profitability

Trailing EPS($0.28)
Net Income$-15,430,000.00
Net Margins-36.38%
Return on Equity-34.24%
Return on Assets-27.71%

Miscellaneous

Employees145
Outstanding Shares49,560,000

Intermolecular (NASDAQ:IMI) Frequently Asked Questions

What is Intermolecular's stock symbol?

Intermolecular trades on the NASDAQ under the ticker symbol "IMI."

How were Intermolecular's earnings last quarter?

Intermolecular, Inc. (NASDAQ:IMI) posted its quarterly earnings results on Thursday, February, 12th. The semiconductor company reported ($0.10) earnings per share for the quarter, meeting the consensus estimate of ($0.10). The semiconductor company earned $11 million during the quarter, compared to the consensus estimate of $10.40 million. Intermolecular had a negative net margin of 36.38% and a negative return on equity of 34.24%. View Intermolecular's Earnings History.

When will Intermolecular make its next earnings announcement?

Intermolecular is scheduled to release their next quarterly earnings announcement on Wednesday, February, 7th 2018. View Earnings Estimates for Intermolecular.

Who are some of Intermolecular's key competitors?

Who are Intermolecular's key executives?

Intermolecular's management team includes the folowing people:

  • Bill Roeschlein, Chief Financial Officer, Principal Financial & Principal Accounting Officer (Age 47)
  • Bruce M. McWilliams Ph.D., Non-Executive Chairman of the Board (Age 60)
  • Christian F. Kramer, Director (Age 55)
  • Marvin D. Burkett, Independent Director (Age 74)
  • Irwin B. Federman, Independent Director (Age 81)
  • Matthew S. Furnas, Independent Director (Age 29)

How do I buy Intermolecular stock?

Shares of Intermolecular can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Intermolecular's stock price today?

One share of Intermolecular stock can currently be purchased for approximately $1.25.

How big of a company is Intermolecular?

Intermolecular has a market capitalization of $62.44 million and generates $47.30 million in revenue each year. The semiconductor company earns $-15,430,000.00 in net income (profit) each year or ($0.28) on an earnings per share basis. Intermolecular employs 145 workers across the globe.

How can I contact Intermolecular?

Intermolecular's mailing address is 3011 NORTH FIRST STREET, SAN JOSE CA, 95134. The semiconductor company can be reached via phone at 408-582-5700 or via email at [email protected]


MarketBeat Community Rating for Intermolecular (IMI)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  66 (Vote Outperform)
Underperform Votes:  89 (Vote Underperform)
Total Votes:  155
MarketBeat's community ratings are surveys of what our community members think about Intermolecular and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Intermolecular (NASDAQ:IMI) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.002.002.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Intermolecular (NASDAQ:IMI) Consensus Price Target History

Price Target History for Intermolecular (NASDAQ:IMI)

Intermolecular (NASDAQ:IMI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/16/2017Needham & Company LLCReiterated RatingHoldN/AView Rating Details
(Data available from 12/12/2015 forward)

Earnings

Intermolecular (NASDAQ:IMI) Earnings History and Estimates Chart

Earnings by Quarter for Intermolecular (NASDAQ:IMI)

Intermolecular (NASDAQ IMI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/7/2018N/AView Earnings Details
2/9/2017Q416($0.08)($0.05)$10.20 million$10.50 millionViewListenView Earnings Details
2/12/2015Q414($0.10)($0.10)$10.40 million$11.00 millionViewN/AView Earnings Details
10/31/2014Q314($0.09)($0.07)$10.60 million$10.90 millionViewN/AView Earnings Details
8/1/2014Q2 2014($0.19)($0.14)$9.00 million$9.93 millionViewN/AView Earnings Details
5/6/2014Q1($0.05)($0.06)$15.51 million$15.91 millionViewN/AView Earnings Details
2/6/2014($0.07)($0.07)$15.57 million$15.60 millionViewN/AView Earnings Details
2/6/2014($0.07)($0.07)$15.57 million$15.60 millionViewN/AView Earnings Details
2/6/2014Q413($0.07)($0.07)$15.57 million$15.60 millionViewN/AView Earnings Details
10/24/2013Q313($0.03)($0.05)$15.50 million$17.70 millionViewN/AView Earnings Details
7/25/2013Q213($0.01)$0.01$16.54 million$16.60 millionViewN/AView Earnings Details
4/25/2013Q1 2013$0.03$16.97 million$17.43 millionViewN/AView Earnings Details
2/7/2013Q4 2013$0.01$0.03$16.68 million$17.40 millionViewN/AView Earnings Details
10/25/2012($0.03)$0.02ViewN/AView Earnings Details
7/26/2012($0.03)($0.02)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Intermolecular (NASDAQ:IMI) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Intermolecular (NASDAQ:IMI)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Intermolecular (NASDAQ IMI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 45.40%
Institutional Ownership Percentage: 37.55%
Insider Trades by Quarter for Intermolecular (NASDAQ:IMI)
Insider Trades by Quarter for Intermolecular (NASDAQ:IMI)

Intermolecular (NASDAQ IMI) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/7/2017Lloyd I Miller IIIMajor ShareholderBuy600$0.86$516.00View SEC Filing  
9/5/2017Lloyd I Miller IIIMajor ShareholderBuy1,909$0.86$1,641.74View SEC Filing  
9/1/2017Lloyd I Miller IIIMajor ShareholderBuy34,109$0.86$29,333.74View SEC Filing  
8/31/2017Lloyd I Miller IIIMajor ShareholderBuy1,612$0.86$1,386.32View SEC Filing  
8/28/2017Lloyd I Miller IIIMajor ShareholderBuy400$0.86$344.00View SEC Filing  
8/21/2017Lloyd I Miller IIIMajor ShareholderBuy300$0.86$258.00View SEC Filing  
6/22/2017Lloyd I Miller IIIMajor ShareholderBuy80,000$0.88$70,400.00View SEC Filing  
6/20/2017Lloyd I Miller IIIMajor ShareholderBuy6,659$0.86$5,726.74View SEC Filing  
5/24/2017Lloyd I Miller IIIMajor ShareholderBuy107$0.85$90.95View SEC Filing  
5/23/2017Lloyd I Miller IIIMajor ShareholderBuy29,020$0.85$24,667.00View SEC Filing  
5/22/2017Lloyd I Miller IIIMajor ShareholderBuy5,590$0.85$4,751.50View SEC Filing  
5/19/2017Lloyd I Miller IIIMajor ShareholderBuy6,564$0.85$5,579.40View SEC Filing  
5/18/2017Lloyd I Miller IIIMajor ShareholderBuy2,132$0.85$1,812.20View SEC Filing  
5/17/2017Lloyd I Miller IIIMajor ShareholderBuy12,743$0.85$10,831.55View SEC Filing  
5/16/2017Lloyd I Miller IIIMajor ShareholderBuy9,325$0.85$7,926.25View SEC Filing  
5/15/2017Lloyd I Miller IIIMajor ShareholderBuy8,817$0.85$7,494.45View SEC Filing  
5/12/2017Lloyd I Miller IIIMajor ShareholderBuy4,642$0.85$3,945.70View SEC Filing  
2/28/2017Rick NeelyCFOSell1,145$1.02$1,167.90View SEC Filing  
12/16/2016William C MartinMajor ShareholderBuy214,294$1.02$218,579.88View SEC Filing  
11/18/2016William C MartinMajor ShareholderBuy400$1.00$400.00View SEC Filing  
11/17/2016William C MartinMajor ShareholderBuy990,452$0.85$841,884.20View SEC Filing  
10/14/2016Rick NeelyCFOSell4,586$0.95$4,356.70View SEC Filing  
8/15/2016Irwin FedermanDirectorBuy100,000$1.25$125,000.00View SEC Filing  
8/12/2016William C MartinMajor ShareholderBuy10,944$1.25$13,680.00View SEC Filing  
8/11/2016William C MartinMajor ShareholderBuy2,165,634$1.02$2,208,946.68View SEC Filing  
5/17/2016Irwin FedermanDirectorBuy100,000$1.90$190,000.00View SEC Filing  
3/1/2016Rick NeelyCFOSell940$2.18$2,049.20View SEC Filing  
2/24/2016Irwin FedermanDirectorBuy5,900$2.12$12,508.00View SEC Filing  
2/16/2016Irwin FedermanDirectorBuy4,716$2.12$9,997.92View SEC Filing  
2/11/2016Irwin FedermanDirectorBuy17,878$2.10$37,543.80View SEC Filing  
12/9/2015Irwin FedermanDirectorBuy5,603$2.05$11,486.15View SEC Filing  
12/8/2015Irwin FedermanDirectorBuy1,600$2.04$3,264.00View SEC Filing  
12/7/2015Irwin FedermanDirectorBuy200$2.05$410.00View SEC Filing  
11/17/2015Irwin FedermanDirectorBuy4,600$2.03$9,338.00View SEC Filing  
11/16/2015Irwin FedermanDirectorBuy64,300$2.00$128,600.00View SEC Filing  
10/5/2015Rick NeelyCFOSell3,807$1.86$7,081.02View SEC Filing  
9/23/2015William C MartinMajor ShareholderBuy283,913$1.75$496,847.75View SEC Filing  
6/25/2015Rick NeelyCFOSell33,407$1.95$65,143.65View SEC Filing  
11/13/2014Irwin FedermanDirectorBuy50,000$2.14$107,000.00View SEC Filing  
11/4/2014Irwin FedermanDirectorBuy100,000$2.25$225,000.00View SEC Filing  
10/3/2014Rick NeelyCFOSell3,884$2.31$8,972.04View SEC Filing  
7/29/2014Hector Thomas BlancoVPSell3,032$2.24$6,791.68View SEC Filing  
7/23/2014Hector Thomas BlancoVPSell1,968$2.20$4,329.60View SEC Filing  
5/1/2014Sandeep JaggiSVPSell5,569$2.70$15,036.30View SEC Filing  
3/31/2014Raj JammySVPSell5,356$2.76$14,782.56View SEC Filing  
3/3/2014Tony ChiangCTOSell1,476$2.64$3,896.64View SEC Filing  
2/6/2014David LazovskyCEOSell4,552$4.02$18,299.04View SEC Filing  
1/28/2014Sandeep JaggiSVPSell2,322$4.06$9,427.32View SEC Filing  
1/28/2014Sandeep NijhawanVPSell4,064$4.06$16,499.84View SEC Filing  
1/28/2014Tony ChiangCTOSell1,742$4.06$7,072.52View SEC Filing  
12/10/2013David LazovskyCEOSell38,500$5.33$205,205.00View SEC Filing  
12/4/2013Tony ChiangCTOSell30,000$5.52$165,600.00View SEC Filing  
11/8/2013David LazovskyCEOSell38,500$5.58$214,830.00View SEC Filing  
10/8/2013David LazovskyCEOSell38,500$5.80$223,300.00View SEC Filing  
9/9/2013David E LazovskyCEOSell38,500$5.89$226,765.00View SEC Filing  
9/5/2013Tony ChiangCTOSell39,003$5.97$232,847.91View SEC Filing  
8/7/2013David LazovskyCEOSell38,500$6.20$238,700.00View SEC Filing  
8/1/2013Tony P ChiangCTOSell48,000$6.31$302,880.00View SEC Filing  
7/16/2013Peter L EidelmanCFOSell21,753$6.96$151,400.88View SEC Filing  
7/8/2013David E LazovskyCEOSell38,500$7.34$282,590.00View SEC Filing  
7/3/2013Tony P ChiangCTOSell78,000$7.23$563,940.00View SEC Filing  
6/17/2013Peter L EidelmanCFOSell6,500$7.30$47,450.00View SEC Filing  
6/7/2013David E LazovskyCEOSell38,500$8.22$316,470.00View SEC Filing  
6/3/2013James Craig HunterSVPSell3,500$8.43$29,505.00View SEC Filing  
5/23/2013Tony P ChiangCTOSell52,926$8.40$444,578.40View SEC Filing  
5/16/2013Peter L EidelmanCFOSell6,500$8.68$56,420.00View SEC Filing  
3/25/2013Tony P ChiangCTOSell25,000$9.53$238,250.00View SEC Filing  
2/26/2013Tony P ChiangCTOSell72,612$9.55$693,444.60View SEC Filing  
2/21/2013Bruce M McwilliamsDirectorSell2,132$9.64$20,552.48View SEC Filing  
1/17/2013Bruce M McwilliamsDirectorSell21,200$9.27$196,524.00View SEC Filing  
12/3/2012John R BehnkeSVPSell2,500$6.99$17,475.00View SEC Filing  
10/8/2012David E LazovskyCEOSell26,810$7.23$193,836.30View SEC Filing  
9/5/2012James Craig HunterSVPSell3,500$7.20$25,200.00View SEC Filing  
8/23/2012Tony P ChiangCTOSell14,266$7.15$102,001.90View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Intermolecular (NASDAQ IMI) News Headlines

Source:
DateHeadline
ETFs with exposure to Intermolecular, Inc. : November 21, 2017ETFs with exposure to Intermolecular, Inc. : November 21, 2017
finance.yahoo.com - November 21 at 8:02 PM
Intermolecular and SITRI Form Strategic Alliance to Accelerate Materials Innovation - "More than Moore"Intermolecular and SITRI Form Strategic Alliance to Accelerate Materials Innovation - "More than Moore"
finance.yahoo.com - November 20 at 8:15 PM
Intermolecular To Participate In The Sixth Annual NYC Investor Summit 2017Intermolecular To Participate In The Sixth Annual NYC Investor Summit 2017
finance.yahoo.com - November 17 at 6:32 AM
Intermolecular, Inc. :IMI-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017Intermolecular, Inc. :IMI-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017
finance.yahoo.com - November 11 at 11:54 AM
ETFs with exposure to Intermolecular, Inc. : November 10, 2017ETFs with exposure to Intermolecular, Inc. : November 10, 2017
finance.yahoo.com - November 11 at 11:54 AM
Edited Transcript of IMI earnings conference call or presentation 2-Nov-17 9:00pm GMTEdited Transcript of IMI earnings conference call or presentation 2-Nov-17 9:00pm GMT
finance.yahoo.com - November 5 at 7:22 PM
Intermoleculars (IMI) CEO Chris Kramer on Q3 2017 Results - Earnings Call TranscriptIntermolecular's (IMI) CEO Chris Kramer on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 4 at 2:13 AM
Intermolecular Announces Third Quarter 2017 Financial ResultsIntermolecular Announces Third Quarter 2017 Financial Results
www.bizjournals.com - November 3 at 9:46 AM
Intermolecular, Inc. (IMI) Set to Announce Quarterly Earnings on ThursdayIntermolecular, Inc. (IMI) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - October 26 at 5:51 AM
Intermolecular To Report Third Quarter Fiscal 2017 Financial Results on November 2, 2017Intermolecular To Report Third Quarter Fiscal 2017 Financial Results on November 2, 2017
finance.yahoo.com - October 18 at 1:14 AM
Applied Micro Circuits (AMCC) & Intermolecular (IMI) Head-To-Head AnalysisApplied Micro Circuits (AMCC) & Intermolecular (IMI) Head-To-Head Analysis
www.americanbankingnews.com - October 17 at 12:56 PM
ETFs with exposure to Intermolecular, Inc. : October 10, 2017ETFs with exposure to Intermolecular, Inc. : October 10, 2017
finance.yahoo.com - October 10 at 7:14 PM
Intermolecular (IMI) versus Coherent (COHR) Head-To-Head ReviewIntermolecular (IMI) versus Coherent (COHR) Head-To-Head Review
www.americanbankingnews.com - October 8 at 8:08 PM
Intermolecular (IMI) and The Competition Head-To-Head ReviewIntermolecular (IMI) and The Competition Head-To-Head Review
www.americanbankingnews.com - September 28 at 2:28 PM
What Does Intermolecular Inc’s (IMI) Share Price Indicate?What Does Intermolecular Inc’s (IMI) Share Price Indicate?
finance.yahoo.com - September 15 at 12:47 AM
Intermolecular, Inc. (IMI) Major Shareholder Lloyd I. Miller III Buys 34,109 SharesIntermolecular, Inc. (IMI) Major Shareholder Lloyd I. Miller III Buys 34,109 Shares
www.americanbankingnews.com - September 5 at 1:38 PM
ETFs with exposure to Intermolecular, Inc. : August 31, 2017ETFs with exposure to Intermolecular, Inc. : August 31, 2017
finance.yahoo.com - August 31 at 7:49 PM
Intermolecular, Inc. :IMI-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017Intermolecular, Inc. :IMI-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
finance.yahoo.com - August 26 at 6:13 AM
Intermolecular to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017Intermolecular to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017
finance.yahoo.com - August 25 at 7:05 AM
Intermolecular (IMI) versus Exar (EXAR) Head-To-Head SurveyIntermolecular (IMI) versus Exar (EXAR) Head-To-Head Survey
www.americanbankingnews.com - August 18 at 12:22 AM
Edited Transcript of IMI earnings conference call or presentation 8-Aug-17 9:00pm GMTEdited Transcript of IMI earnings conference call or presentation 8-Aug-17 9:00pm GMT
finance.yahoo.com - August 9 at 5:34 AM
Intermolecular Announces Second Quarter 2017 Financial ResultsIntermolecular Announces Second Quarter 2017 Financial Results
finance.yahoo.com - August 8 at 7:30 PM
Intermoleculars High-Throughput Experimentation Platform Speeds Discovery of Next-Generation Non-Volatile MemoriesIntermolecular's High-Throughput Experimentation Platform Speeds Discovery of Next-Generation Non-Volatile Memories
finance.yahoo.com - August 1 at 3:25 PM
Intermolecular To Report Second Quarter Fiscal 2017 Financial Results on August 8, 2017Intermolecular To Report Second Quarter Fiscal 2017 Financial Results on August 8, 2017
finance.yahoo.com - July 14 at 3:50 AM
Intermolecular reports 1Q lossIntermolecular reports 1Q loss
marketbeat.com - May 4 at 7:57 PM
Intermolecular Announces Restructuring Initiative and Changes in its Leadership TeamIntermolecular Announces Restructuring Initiative and Changes in its Leadership Team
us.rd.yahoo.com - March 29 at 6:25 PM
4:18 pm Intermolecular appoints Bill Roeschlein, currently VP of Finance and Corporate Controller, as CFO; also announces restructuring initiative that will lower costs by approx. $4 mln in 20174:18 pm Intermolecular appoints Bill Roeschlein, currently VP of Finance and Corporate Controller, as CFO; also announces restructuring initiative that will lower costs by approx. $4 mln in 2017
us.rd.yahoo.com - March 29 at 6:25 PM
INTERMOLECULAR INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in Directors or PrinINTERMOLECULAR INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in Directors or Prin
biz.yahoo.com - March 29 at 6:25 PM
INTERMOLECULAR INC Files SEC form 10-K, Annual ReportINTERMOLECULAR INC Files SEC form 10-K, Annual Report
biz.yahoo.com - March 3 at 5:53 PM
Q4 2016 Intermolecular Inc Earnings Release - After Market CloseQ4 2016 Intermolecular Inc Earnings Release - After Market Close
us.rd.yahoo.com - February 10 at 6:39 PM
INTERMOLECULAR INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibiINTERMOLECULAR INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
us.rd.yahoo.com - February 10 at 6:39 PM
Intermolecular Announces Fourth Quarter 2016 and Full Year 2016 Financial ResultsIntermolecular Announces Fourth Quarter 2016 and Full Year 2016 Financial Results
www.bizjournals.com - February 9 at 6:49 PM
INTERMOLECULAR INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsINTERMOLECULAR INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
biz.yahoo.com - November 16 at 5:52 PM
Intermolecular Announces Third Quarter 2016 Financial ResultsIntermolecular Announces Third Quarter 2016 Financial Results
www.prnewswire.com - November 2 at 5:50 PM
Q3 2016 Intermolecular Inc Earnings Release - After Market CloseQ3 2016 Intermolecular Inc Earnings Release - After Market Close
biz.yahoo.com - November 2 at 9:02 AM
INTERMOLECULAR INC Files SEC form 8-K, Change in Directors or Principal OfficersINTERMOLECULAR INC Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - September 23 at 8:34 AM
Unusual 11 Mid-Day Movers 8/5: (LNTH) (PTCT) (WLDN) Higher; (CPSI) (HDP) (IMI) LowerUnusual 11 Mid-Day Movers 8/5: (LNTH) (PTCT) (WLDN) Higher; (CPSI) (HDP) (IMI) Lower
www.streetinsider.com - August 5 at 5:45 PM
Q2 2016 Intermolecular Inc Earnings Release - After Market CloseQ2 2016 Intermolecular Inc Earnings Release - After Market Close
biz.yahoo.com - August 4 at 8:38 AM
INTERMOLECULAR INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersINTERMOLECULAR INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - May 27 at 4:46 PM

SEC Filings

Intermolecular (NASDAQ:IMI) SEC Filings

DateFilerForm TypeView

Social Media

Financials

Intermolecular (NASDAQ:IMI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Intermolecular (NASDAQ IMI) Stock Chart for Tuesday, December, 12, 2017

Loading chart…

This page was last updated on 12/12/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.